文章摘要
脉搏压变异度指导的液体管理对腹腔镜肝切除术患者早期预后的影响
Effects of pulse pressure variation-guided fluid therapy on early prognosis in patients undergoing laparoscopic liver resection
  
DOI:10.12089/jca.2022.02.002
中文关键词: 脉搏压变异度  腹腔镜  肝切除术  目标导向液体治疗  早期预后
英文关键词: Pulse pressure variation  Laparoscope  Liver resection  Goal-directed fluid therapy  Early prognosis
基金项目:南京市青年卫生人才项目(QRX17013);南京市卫生科技发展专项资金项目(YKK17084)
作者单位E-mail
季晶晶 210008,南京大学医学院附属鼓楼医院麻醉科  
陈鲁宁 210008,南京大学医学院附属鼓楼医院麻醉科  
田亚丽 210008,南京大学医学院附属鼓楼医院麻醉科  
马倩 210008,南京大学医学院附属鼓楼医院麻醉科  
石雪朵 210008,南京大学医学院附属鼓楼医院麻醉科  
余德才 210008,南京大学医学院附属鼓楼医院麻醉科  
朱新华 210008,南京大学医学院附属鼓楼医院麻醉科  
仇毓东 210008,南京大学医学院附属鼓楼医院麻醉科  
李冰冰 210008,南京大学医学院附属鼓楼医院麻醉科 libingbing@nju.edu.cn 
摘要点击次数: 2492
全文下载次数: 816
中文摘要:
      
目的 探讨脉搏压变异度(PPV)指导的液体管理策略对腹腔镜肝切除术(LLR)患者早期预后的影响。
方法 选择2018年10月至2019年8月择期行LLR的患者62例,男32例,女30例,年龄18~64岁,BMI 18~30 kg/m2,ASA Ⅱ或Ⅲ级。采用随机数字表法将患者分为两组:PPV导向液体治疗组(PPV组,n=32)和低中心静脉压组(LCVP组,n=30)。PPV组于肝实质离断阶段维持PPV 13%~20%。LCVP组于肝实质离断阶段维持CVP 2~5 cmH2O。记录术中各类液体入量、出血量、输血量、尿量、术前、肝脏横断面完成时和术毕血乳酸浓度、手术时间、呋塞米用量、血管活性药使用例数及术中低血压发生例数。记录术前1 d及术后1、3 d Hb、Plt、ALT、AST、Alb、TBil、Cr、BUN、CRP、MDA浓度。记录术后首次肛门排气时间、首次排便时间、首次进食时间、首次下床活动时间、术后住院时间、术后并发症发生情况等。
结果 PPV组术中出血量明显少于LCVP组[(254.1±201.1)ml vs (405.0±312.8)ml,P<0.05],输血发生率明显低于LCVP组(6% vs 27%,P<0.05)。两组术前1 d及术后1、3 d Hb、Plt、ALT、AST、Alb、TBil、Cr、BUN、CRP、MDA浓度、术后首次肛门排气时间、首次排便时间、首次进食时间、首次下床活动时间、术后住院时间、术后并发症发生率差异均无统计学意义。
结论 以PPV作为LLR术中液体管理目标不仅具有成本低、使用方便等优势,并且安全可行,可以作为控制术中出血量的管理方法,且不影响患者早期预后。
英文摘要:
      
Objective To investigate the effect of pulse pressure variation (PPV)-guided fluid therapy on early prognosis in patients undergoing laparoscopic liver resection (LLR).
Methods Sixty-two patients scheduled for elective LLR from October 2018 to August 2019, 32 males and 30 females, aged 18-64 years, BMI 18-30 kg/m2, ASA physical status Ⅱ or Ⅲ, were enrolled and randomly divided into 2 groups using random number table method: PPV-guided fluid therapy group (group PPV, n = 32) and low central venous pressure (LCVP) group (group LCVP, n = 30). Fluid management strategy for group PPV was to guarantee PPV at the level of 13%-20% during the hepatic transection stage. Fluid management strategy for group LCVP was maintained at the level of 2-5 cmH2O during the hepatic transection stage. All kinds of fluid intake, the intraoperative blood loss, blood transfusion, urine volume, lactic acid concentration, the duration of operation, the use of furosemidum, the use of vasoactive drugs, and the occurrence of intraoperative hypotension were recorded. The results of laboratory examination including Hb, Plt, ALT, AST, Alb, TBil, Cr, BUN, CRP, and MDA contents were recorded 1 day before surgery, 1 day and 3 days after surgery. The first time to flatus, the first time to defecation, the first time to oral after surgery, the time to ambulation, the length of hospital stay after surgery, and the occurrence of complications were also recorded.
Results The total intraoperative blood loss of patients in group PPV was significantly less than patients in group LCVP [(254.1 ± 201.1)ml vs (405.0 ± 312.8)ml, P < 0.05]. The requirement for intraoperative transfusion was decreased in group PPV (6% vs 27%, P < 0.05). There were no significant differences in Hb, PLT, ALT, AST, Alb, TBil, Cr, BUN, CRP, and MDA contents 1 day before surgery, 1 day and 3 days after surgery, the first time to flatus, the first time to defecation, the first time to oral after surgery, the time to ambulation, the length of hospital stay after surgery, and the occurrence of complications between the two groups.
Conclusion Taking PPV as the goal of intraoperative fluid management in LLR not only have the advantages of lower cost and easy to use, but also a safe way to control intraoperative blood loss without affecting the early prognosis of patients.
查看全文   查看/发表评论  下载PDF阅读器
关闭